|This article is a Stub. You can help MEpedia by expanding it.|
Imunovir or inosine pranobex is an immunostimulant. In a pilot study of sixteen chronic fatigue syndrome patients it increased natural killer cell activity and resulted in a clinical improvement in 60% of patients.
References[edit | edit source]
- Patarca-Montero, Roberto (2014). Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?. Routledge. pp. 41–42. ISBN 9781135416294.